SwingTrade Member Forum

[Rawnoc]

RBC Life Sciences Supports Clean Energy by Purchasing Renewable Energy Credits to
Offset 100 Percent of Its Electricity Usage

IRVING, Texas, Jan 12, 2009 /PRNewswire-FirstCall via COMTEX/ -- RBC Life
Sciences (RBCL), a global provider of proprietary nutritional supplements, wound
care and pain management products, is offsetting 100 percent of its electricity
usage for two years as part of a company-wide green initiative.

RBC Life Sciences is purchasing 2,561,550 kilowatt hours of renewable energy
credits, which will help to avoid more than 3.4 million pounds of carbon dioxide
pollution. Over a two-year span, this commitment has an impact comparable to
planting more than 14,000 mature trees and avoiding the pollution associated with
driving 3.4 million miles in an average car.

RBC Life Sciences has also embarked on other energy-saving initiatives. The
company uses recycled paper as cushioning in product shipments, new printer ink
technology that will eliminate hundreds of pounds of used printer cartridges and
special lighting and printing technologies that drastically reduce energy
consumption.

"RBC Life Sciences' commitment to sustainable energy meshes well with the
company's focus on providing nutritional supplements and skin care products that
highlight natural ingredients," said company President and CEO John W. Price.
"This company-wide commitment to reduce our carbon footprint is part of a larger
company effort to promote clean energy projects and help America become less
dependent on fossil fuels."

RBC Life Sciences is purchasing the renewable energy credits from Renewable
Choice Energy, a Colorado-based company that works with the nation's alternative
energy sector. Every credit purchased helps fund new renewable energy projects,
such as wind farms.

About RBC Life SciencesRBC Life Sciences develops, manufactures and markets
high-quality nutritional supplements and personal care products to a growing
population of consumers seeking wellness and a healthy lifestyle. Under its MPM
Medical Inc. brand, RBC Life Sciences also develops and markets to health care
professionals in the United States proprietary prescription and nonprescription
products for advanced wound care and pain management. All products are tested for
quality assurance in-house, and by outside independent laboratories, to comply
with regulations in the U.S. and in more than thirty countries in which the
products are distributed. For more information, visit the Company's Web site at
http://www.rbclifesciences.com.

The statements above, other than statements of historical fact, may be
forward-looking. Actual events will be dependent upon a number of factors and
risks including, but not limited to, changes in plans by the Company's
management, delays or problems in production, changes in the regulatory process,
changes in market trends, and a number of other factors and risks described from
time to time in the Company's filings with the Securities and Exchange
Commission.

SOURCE RBC Life Sciences
http://www.rbclifesciences.com


Copyright (C) 2009 PR Newswire. All rights reserved